Medical News

RSS

Illicit drug consumption in Europe

Europeans belong to the largest consumers of illicit drugs, absorbing about one fifth of the global heroin, cocaine and cannabis supply, as well as one third of ecstasy production (UNODC World Drug report, 2008). However, the vast majority of Europeans have never tried any illicit substance. In popular perception, illicit drugs still represent alien cultures challenging traditional European patterns, including consumption of our favourite drugs - alcoholic beverages.

21 Jan 2010

Christiana Care Health System earns Gold Seal of Approval for Primary Stroke Centers

Christiana Care Health System has earned the Gold Seal of Approval(TM) from The Joint Commission for Primary Stroke Centers. Christiana Care earned this distinction after the Joint Commission conducted an on-site review in November 2009.

21 Jan 2010

FRC's statement on Massachusetts Senate election results

"President Obama's defeat yesterday is the culmination of the town halls, tea parties, and other efforts of the millions of Americans who continue speaking out against the takeover of our health care system.

21 Jan 2010

Efficacy of neurofeedback in treating ADD/ADHD

On January 22, the Potomac Institute for Policy Studies will present a guest lecture by Don DuRousseau, founder and CEO of Human Bionics LLC, a neurotechnology company specializing in brain-computer interface (BCI) systems. Mr. DuRousseau will explore the use of neurotechnology techniques, including the increasingly popular neurofeedback, as a treatment for ADD/ADHD.

21 Jan 2010

Results of two pivotal Phase III clinical trials with oral FTY720 published

Results of the TRANSFORMS and FREEDOMS studies, the two pivotal Phase III clinical trials with oral FTY720 (fingolimod), have been published in The New England Journal of Medicine, providing comprehensive evidence to support the efficacy and safety profile of this first-in-class therapy for multiple sclerosis (MS).

21 Jan 2010

Benefits of NIH funding through the Recovery Act

In advance of the one-year anniversary of the Recovery and Reinvestment Act's enactment on February 17, twenty of the nation's leading research institutions, patient advocates and biomedical industry have released a detailed report on how Recovery Act funding of medical research through the National Institutes of Health (NIH) is at work across the country in the service of better health and a healthier economy.

21 Jan 2010

Natural grass/cleat combination lowers strain and less likely to cause ACL injury

Athletes put less strain on their anterior cruciate ligament (ACL) while making a cut on a natural grass surface while wearing a cleat.

21 Jan 2010

Phase 3 clinical trial results of Inspire Pharmaceuticals' PROLACRIA announced

Inspire Pharmaceuticals, Inc. announced today that its Phase 3 clinical trial (Trial 03-113) of PROLACRIA™ (diquafosol tetrasodium ophthalmic solution) 2% for the treatment of dry eye disease did not meet its primary endpoint (p = 0.526) or its secondary endpoint (p = 0.368).

21 Jan 2010

Moxifloxacin more favorable than amoxicillin/clavulanate for COPD exacerbations

Chronic obstructive pulmonary disease (COPD) affects a large number of subjects worldwide and is characterised by a progressively rising epidemiological, clinical and socio-economic impact. The objectives of treatment are to decrease the burden of the disease through relief of symptoms, improvement of exercise tolerance, and prevention and treatment of exacerbations.

21 Jan 2010

Cord Blood America to provide BioE's PrepaCyte CB Processing System for its Las Vegas operations

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has contracted with BioE, St. Paul, Minnesota, to provide the newest "state of the art" cord blood processing systems for its Las Vegas operations.

21 Jan 2010

MaMayo Clinic experts available to discuss health issues and concerns related to Olympic Games

Mayo Clinic's medical experts are sources of in-depth expertise and commentary about health issues and background related to the Olympic Games and Olympians. Below is a sampling of Mayo Clinic experts available to discuss numerous topics related to the Olympic Games, including concussions, performance enhancing drugs, sports psychology, joint injuries, etc. Mayo has satellite capability for broadcast requests.

21 Jan 2010

BioLife Solutions announces biologic packaging products pre-filled with GMP biopreservation media

BioLife Solutions, Inc., a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, and OriGen Biomedical, a leading provider of biologic packaging products for research and clinical blood and cell-based therapies, today announced that the companies will introduce sterile standard and custom biologic packaging products pre-filled with BioLife's serum-free, protein-free HypoThermosol® cell and tissue storage/transport media and CryoStor™ cryopreservation media.

21 Jan 2010

Latest interdisciplinary project from Wiley-Blackwell

Cognitive Science represents the exploration of the human mind in the hope of answering some of humanity's oldest questions, from the origin of thought to the nature of knowledge. Today cognitive scientists link these ancient questions to the newest emerging fields of research in various areas, an approach epitomized by WIREs Cognitive Science, the latest interdisciplinary project from Wiley-Blackwell.

21 Jan 2010

MD Physician Services appoints State Street to provide investment services for CAD$15.6 billion in assets

State Street Corporation, one of the world's leading providers of financial services to institutional investors, announced today that it has been appointed by MD Physician Services Inc. (MDPSI) to provide a range of investment services for CAD$15.6 billion in assets including custody, fund accounting, and fund valuation services.

21 Jan 2010

WIREs Cognitive Science explores the rise of neurolaw

What if a jury could decide a man's guilt through mind reading? What if reading a defendant's memory could betray their guilt? And what constitutes 'intent' to commit murder? These are just some of the issues debated and reviewed in the inaugural issue of WIREs Cognitive Science, the latest interdisciplinary project from Wiley-Blackwell, which for registered institutions will be free for the first two years.

21 Jan 2010

First DataBank signs licensing agreement with SIS

First DataBank, a leading provider of drug databases that help drive patient safety, and Surgical Information Systems (SIS), a provider of feature-rich perioperative software solutions, announced today they have signed an agreement whereby First DataBank will license its suite of comprehensive drug information and associated developer software to Surgical Information Systems to enable the integration of new functionality for drug screening, dosing and documentation within the SIS suite of interoperable surgery solutions.

21 Jan 2010

Study demonstrates BTG2 gene is crucial for neurogenesis and contextual memory function

The birth of new neurons, a process called neurogenesis, is continuously occurring in the brain, not only during development but also during adulthood within two specialized areas, the hippocampus and the subventricular zone.

21 Jan 2010

UnitedHealth Group announces its revenues and net earnings in 2009

UnitedHealth Group today reported growth in revenues and net earnings per share in 2009. The Company earned $0.81 per share in the fourth quarter, bringing full year 2009 net earnings to $3.24 per share.

21 Jan 2010

International Medical Corps sets up mobile medical unit at epicenter of Haiti earthquake

A 6.1-magnitude aftershock hit Haiti at 6:03 am Eastern Time. All International Medical Corps staff and medical teams are unharmed and are now working to assess the damage left by the strongest aftershock since the 7.0 earthquake that hit Haiti eight days ago.

21 Jan 2010

USPTO issues Notice of Allowance for IntelGenx's bupropion patent

IntelGenx Corp. ("IntelGenx") today announced that the U.S. Patent and Trademark Office ("USPTO") has issued a formal Notice of Allowance for a key patent application protecting IntelGenx's CPI-300, a novel, high strength formulation of bupropion hydrochloride ("HCl"), the active ingredient in Wellbutrin XL(R).

21 Jan 2010

Medical News

Illicit drug consumption in Europe

Christiana Care Health System earns Gold Seal of Approval for Primary Stroke Centers

FRC's statement on Massachusetts Senate election results

Efficacy of neurofeedback in treating ADD/ADHD

Results of two pivotal Phase III clinical trials with oral FTY720 published

Benefits of NIH funding through the Recovery Act

Natural grass/cleat combination lowers strain and less likely to cause ACL injury

Phase 3 clinical trial results of Inspire Pharmaceuticals' PROLACRIA announced

Moxifloxacin more favorable than amoxicillin/clavulanate for COPD exacerbations

Cord Blood America to provide BioE's PrepaCyte CB Processing System for its Las Vegas operations

MaMayo Clinic experts available to discuss health issues and concerns related to Olympic Games

BioLife Solutions announces biologic packaging products pre-filled with GMP biopreservation media

Latest interdisciplinary project from Wiley-Blackwell

MD Physician Services appoints State Street to provide investment services for CAD$15.6 billion in assets

WIREs Cognitive Science explores the rise of neurolaw

First DataBank signs licensing agreement with SIS

Study demonstrates BTG2 gene is crucial for neurogenesis and contextual memory function

UnitedHealth Group announces its revenues and net earnings in 2009

International Medical Corps sets up mobile medical unit at epicenter of Haiti earthquake

USPTO issues Notice of Allowance for IntelGenx's bupropion patent

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Extending the reach of Amperia™

Latest News